How many drugs treat Pituitary dwarfism?

Drug Landscape tracks 3 marketed treatments for Pituitary dwarfism (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/pituitary-dwarfism.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Pituitary dwarfism — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pituitary dwarfism (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Pituitary dwarfism, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Omnitrope	Somatropin	Serono	Recombinant human growth hormone	Dimeric GH receptors on cell membranes of target tissues	1976-01-01
Omnitrope	Omnitrope	Sandoz		Growth hormone receptor
somatropine	somatropine	Sanofi		Growth hormone receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Pituitary dwarfism
Sandoz · 1 drug in Pituitary dwarfism
Sanofi · 1 drug in Pituitary dwarfism
Serono · 1 drug in Pituitary dwarfism

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Pituitary dwarfism:

Cite this brief

Drug Landscape (2026). Pituitary dwarfism — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pituitary-dwarfism. Accessed 2026-06-10.

Pituitary dwarfism full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing